$JAGX· SEC filing ·

JAGX Q1 2026 Revenue $20.3M, Net Loss $7.0M, EPS -$13.60

Jaguar Health, Inc. · PHARMACEUTICAL PREPARATIONS · Now $3.27

-15% in 3d after detection

Post-detection moves

1h
1d
-5.4%
3d
-15%
7d
30d

Get alerts like this in real time

Push notifications the moment a signal fires. No spam, no crypto, no fluff.

Download for iOS